BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Oct 14, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zonegran zonisamide regulatory update

Eisai said the European Commission approved a label expansion for Zonegran zonisamide to include use as adjunctive therapy to treat partial seizures with or without secondary generalization in adolescents...

Read the full 124 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >